熱門資訊> 正文
TRxADE HEALTH收到纳斯达克关于延迟提交年度报告的通知
2024-04-24 05:26
- TRxADE HEALTH (NASDAQ:MEDS) on Tuesday said it has received a notice from Nasdaq, indicating that because the company had not yet filed its Annual Report on Form 10-K for the 2023 fiscal year, it was not compliant with the requirement for continued listing.
- MEDS +7.69% after hours to $7.0.
- Source: Press Release
More on Trxade Group
- Financial information for Trxade Group
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。